This report contains market size and forecasts of Short Bowel Syndrome(SBS) in Global, including the following market information:
Global Short Bowel Syndrome(SBS) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Short Bowel Syndrome(SBS) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Short Bowel Syndrome(SBS) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Short Bowel Syndrome(SBS) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Short Bowel Syndrome(SBS) Market Segment Percentages, By Type, 2020 (%)
Oral Route
Parental Route
China Short Bowel Syndrome(SBS) Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Short Bowel Syndrome(SBS) Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Retail Pharmacies
Global Short Bowel Syndrome(SBS) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Short Bowel Syndrome(SBS) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Short Bowel Syndrome(SBS) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Short Bowel Syndrome(SBS) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Short Bowel Syndrome(SBS) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Short Bowel Syndrome(SBS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Short Bowel Syndrome(SBS) Overall Market Size
2.1 Global Short Bowel Syndrome(SBS) Market Size: 2021 VS 2027
2.2 Global Short Bowel Syndrome(SBS) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Short Bowel Syndrome(SBS) Players in Global Market
3.2 Top Global Short Bowel Syndrome(SBS) Companies Ranked by Revenue
3.3 Global Short Bowel Syndrome(SBS) Revenue by Companies
3.4 Top 3 and Top 5 Short Bowel Syndrome(SBS) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Short Bowel Syndrome(SBS) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Short Bowel Syndrome(SBS) Players in Global Market
3.6.1 List of Global Tier 1 Short Bowel Syndrome(SBS) Companies
3.6.2 List of Global Tier 2 and Tier 3 Short Bowel Syndrome(SBS) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Short Bowel Syndrome(SBS) Market Size Markets, 2021 & 2027
4.1.2 Oral Route
4.1.3 Parental Route
4.2 By Type - Global Short Bowel Syndrome(SBS) Revenue & Forecasts
4.2.1 By Type - Global Short Bowel Syndrome(SBS) Revenue, 2016-2021
4.2.2 By Type - Global Short Bowel Syndrome(SBS) Revenue, 2022-2027
4.2.3 By Type - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Short Bowel Syndrome(SBS) Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Retail Pharmacies
5.2 By Application - Global Short Bowel Syndrome(SBS) Revenue & Forecasts
5.2.1 By Application - Global Short Bowel Syndrome(SBS) Revenue, 2016-2021
5.2.2 By Application - Global Short Bowel Syndrome(SBS) Revenue, 2022-2027
5.2.3 By Application - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Short Bowel Syndrome(SBS) Market Size, 2021 & 2027
6.2 By Region - Global Short Bowel Syndrome(SBS) Revenue & Forecasts
6.2.1 By Region - Global Short Bowel Syndrome(SBS) Revenue, 2016-2021
6.2.2 By Region - Global Short Bowel Syndrome(SBS) Revenue, 2022-2027
6.2.3 By Region - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Short Bowel Syndrome(SBS) Revenue, 2016-2027
6.3.2 US Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.3.3 Canada Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.3.4 Mexico Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Short Bowel Syndrome(SBS) Revenue, 2016-2027
6.4.2 Germany Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.4.3 France Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.4.4 U.K. Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.4.5 Italy Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.4.6 Russia Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.4.7 Nordic Countries Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.4.8 Benelux Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Short Bowel Syndrome(SBS) Revenue, 2016-2027
6.5.2 China Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.5.3 Japan Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.5.4 South Korea Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.5.5 Southeast Asia Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.5.6 India Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Short Bowel Syndrome(SBS) Revenue, 2016-2027
6.6.2 Brazil Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.6.3 Argentina Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue, 2016-2027
6.7.2 Turkey Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.7.3 Israel Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.7.4 Saudi Arabia Short Bowel Syndrome(SBS) Market Size, 2016-2027
6.7.5 UAE Short Bowel Syndrome(SBS) Market Size, 2016-2027
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Short Bowel Syndrome(SBS) Major Product Offerings
7.1.4 Merck Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Takeda
7.2.1 Takeda Corporate Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda Short Bowel Syndrome(SBS) Major Product Offerings
7.2.4 Takeda Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.2.5 Takeda Key News
7.3 Emmaus Medical
7.3.1 Emmaus Medical Corporate Summary
7.3.2 Emmaus Medical Business Overview
7.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Major Product Offerings
7.3.4 Emmaus Medical Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.3.5 Emmaus Medical Key News
7.4 Ardelyx
7.4.1 Ardelyx Corporate Summary
7.4.2 Ardelyx Business Overview
7.4.3 Ardelyx Short Bowel Syndrome(SBS) Major Product Offerings
7.4.4 Ardelyx Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.4.5 Ardelyx Key News
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporate Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Major Product Offerings
7.5.4 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.5.5 Naia Pharmaceuticals Key News
7.6 Nutrinia
7.6.1 Nutrinia Corporate Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Short Bowel Syndrome(SBS) Major Product Offerings
7.6.4 Nutrinia Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.6.5 Nutrinia Key News
7.7 OxThera
7.7.1 OxThera Corporate Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Short Bowel Syndrome(SBS) Major Product Offerings
7.4.4 OxThera Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.7.5 OxThera Key News
7.8 Sancilio Pharmaceuticals
7.8.1 Sancilio Pharmaceuticals Corporate Summary
7.8.2 Sancilio Pharmaceuticals Business Overview
7.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Major Product Offerings
7.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.8.5 Sancilio Pharmaceuticals Key News
7.9 Zealand Pharma
7.9.1 Zealand Pharma Corporate Summary
7.9.2 Zealand Pharma Business Overview
7.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Major Product Offerings
7.9.4 Zealand Pharma Short Bowel Syndrome(SBS) Revenue in Global (2016-2021)
7.9.5 Zealand Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Short Bowel Syndrome(SBS) Market Opportunities & Trends in Global Market
Table 2. Short Bowel Syndrome(SBS) Market Drivers in Global Market
Table 3. Short Bowel Syndrome(SBS) Market Restraints in Global Market
Table 4. Key Players of Short Bowel Syndrome(SBS) in Global Market
Table 5. Top Short Bowel Syndrome(SBS) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Short Bowel Syndrome(SBS) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Short Bowel Syndrome(SBS) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Short Bowel Syndrome(SBS) Product Type
Table 9. List of Global Tier 1 Short Bowel Syndrome(SBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Short Bowel Syndrome(SBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Short Bowel Syndrome(SBS) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Short Bowel Syndrome(SBS) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2022-2027
Table 30. Merck Corporate Summary
Table 31. Merck Short Bowel Syndrome(SBS) Product Offerings
Table 32. Merck Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 33. Takeda Corporate Summary
Table 34. Takeda Short Bowel Syndrome(SBS) Product Offerings
Table 35. Takeda Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 36. Emmaus Medical Corporate Summary
Table 37. Emmaus Medical Short Bowel Syndrome(SBS) Product Offerings
Table 38. Emmaus Medical Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 39. Ardelyx Corporate Summary
Table 40. Ardelyx Short Bowel Syndrome(SBS) Product Offerings
Table 41. Ardelyx Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 42. Naia Pharmaceuticals Corporate Summary
Table 43. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Product Offerings
Table 44. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 45. Nutrinia Corporate Summary
Table 46. Nutrinia Short Bowel Syndrome(SBS) Product Offerings
Table 47. Nutrinia Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 48. OxThera Corporate Summary
Table 49. OxThera Short Bowel Syndrome(SBS) Product Offerings
Table 50. OxThera Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 51. Sancilio Pharmaceuticals Corporate Summary
Table 52. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Product Offerings
Table 53. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
Table 54. Zealand Pharma Corporate Summary
Table 55. Zealand Pharma Short Bowel Syndrome(SBS) Product Offerings
Table 56. Zealand Pharma Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Short Bowel Syndrome(SBS) Segment by Type
Figure 2. Short Bowel Syndrome(SBS) Segment by Application
Figure 3. Global Short Bowel Syndrome(SBS) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Short Bowel Syndrome(SBS) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Short Bowel Syndrome(SBS) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Short Bowel Syndrome(SBS) Revenue in 2020
Figure 8. By Type - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 12. US Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 16. Germany Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 17. France Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 24. China Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 28. India Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 30. Brazil Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue Market Share, 2016-2027
Figure 33. Turkey Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2016-2027
Figure 37. Merck Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Takeda Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Emmaus Medical Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Ardelyx Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Nutrinia Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. OxThera Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Zealand Pharma Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma